Leaderboards/Blood groups and transfusion

Blood groups and transfusion

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Eun‐Ju Lee
NewYork–Presbyterian Hospital
2
Santosh Aiwale
Savitribai Phule Pune University
3
Chieh-Yu Liang
Washington University in St. Louis
4
Afra Anjum
LMU Klinikum
5
Omid Seidizadeh
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
6
Rijo Rajeev
Christ University
7
Valentina Raglianti
European Society for Sexual Medicine
8
Melika Loriamini
University of Toronto
9
Derek de Winter
Leiden University Medical Center
10
Eleonora Petito
University of Perugia

Papers

1
Non-invasive Anemia Detection and Prediagnosis
Journal of Pharmacology and Pharmacotherapeutics|2024
140 cit.
2
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Nature|2024
81 cit.
3
Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants
Kidney International|2024
61 cit.
4
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management
International Journal of Molecular Sciences|2024
51 cit.
5
Aging platelets shift their hemostatic properties to inflammatory functions
Blood|2025
40 cit.
6
Anti-slit Antibodies against Podocin and Kirrel1 in Pediatric and Adult Podocytopathies
Journal of the American Society of Nephrology|2025
37 cit.
7
Publication in Research and Practice in Thrombosis and Haemostasis (2024) [27 citations, W4392792792]
Research and Practice in Thrombosis and Haemostasis|2024
27 cit.
8
Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis
Blood Advances|2024
24 cit.
9
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A
Blood Advances|2024
11 cit.
10
Publication in British Journal of Haematology (2024) [11 citations, W4403802497]
British Journal of Haematology|2024
11 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Adam S. Butterworth
University of Cambridge
2
Erik L. de Graaf
Scope Group (United States)
3
Myrthe E. Sonneveld
University of Amsterdam
4
Anahita Dua
Massachusetts General Hospital
5
Lei Liu
Southern University of Science and Technology
6
Kristen W. Cohen
Moderna Therapeutics (United States)
7
Jordan R. Willis
Scripps Research Institute
8
Iwijn De Vlaminck
Cornell University
9
Étienne Patin
Centre National de la Recherche Scientifique
10
Miguel A. Prado
Proteostasis Therapeutics (United States)

Papers

1
Spatial mapping of the total transcriptome by in situ polyadenylation
Nature Biotechnology|2022
102 cit.
2
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
Immunity|2022
82 cit.
3
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses
Science Translational Medicine|2023
70 cit.
4
Spatiotemporal transcriptomics reveals pathogenesis of viral myocarditis
Nature Cardiovascular Research|2022
67 cit.
5
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans
Science|2025
60 cit.
6
Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation
Proceedings of the National Academy of Sciences|2022
49 cit.
7
Factors associated with successful median arcuate ligament release in an international, multi-institutional cohort
Journal of Vascular Surgery|2022
46 cit.
8
Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study
Emerging Microbes & Infections|2022
43 cit.
9
A spatiotemporal molecular atlas of the ovulating mouse ovary
Proceedings of the National Academy of Sciences|2024
43 cit.
10
Spatial mapping of mobile genetic elements and their bacterial hosts in complex microbiomes
Nature Microbiology|2024
41 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
James B. Bussel
Cornell University
2
John Danesh
University of Cambridge
3
James N. George
University of Oklahoma
4
Willy A. Flegel
National Institutes of Health Clinical Center
5
Richard H. Aster
Versiti Blood Center of Wisconsin
6
Willem H. Ouwehand
NHS Blood and Transplant
7
Samuel J. Machin
University College London
8
Véronique Frémeaux‐Bacchi
Assistance Publique – Hôpitaux de Paris
9
Neal S. Young
National Heart Lung and Blood Institute
10
Zaverio M. Ruggeri
Scripps Research Institute

Papers

1
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
New England Journal of Medicine|2004
3k cit.
2
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Blood|2008
2.7k cit.
3
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
Cell|1996
1.2k cit.
4
Association of Cardiometabolic Multimorbidity With Mortality
JAMA|2015
1.1k cit.
5
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
British Journal of Haematology|2012
862 cit.
6
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus
Science|1993
859 cit.
7
Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.
Journal of Clinical Investigation|1966
833 cit.
8
Platelet Sequestration in Man. I. Methods*
Journal of Clinical Investigation|1964
819 cit.
9
Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow
Cell|1998
806 cit.
10
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
New England Journal of Medicine|2007
805 cit.

Reagents for Blood groups and transfusion

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Agilent/Dako

Rabbit Immunoglobulin, Negative Control

#X0936
View Evidence →
Cell Signaling Technology

Phospho-mTOR (Ser2481) Matched Antibody Pair

#16730$1,726
View Evidence →
Cell Signaling TechnologyEvidence 63

eIF4H (D85F2) Rabbit Monoclonal Antibody

#3469$161,384
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 68

ANP32A (D7Z5U) Rabbit Monoclonal Antibody

#15491$161,351
View Evidence →
Cell Signaling TechnologyEvidence 62

XPB (2C6) Mouse Monoclonal Antibody

#8746$150,351
View Evidence →
Agilent/Dako

Fibrinogen

#F0111
View Evidence →